{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:43:08Z","timestamp":1763746988047,"version":"3.38.0"},"reference-count":34,"publisher":"American Veterinary Medical Association (AVMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p><jats:bold>Objective<\/jats:bold>\u2014To determine whether oral administration of metoclopramide or a commercially available powdered whole grapefruit (PWG) nutraceutical in combination with cyclosporine enhances systemic availability of cyclosporine in dogs.<\/jats:p>\n<jats:p><jats:bold>Sample<\/jats:bold>\u20148 healthy mixed-breed dogs in part 1 and 6 of these 8 dogs in part 2.<\/jats:p>\n<jats:p><jats:bold>Procedures<\/jats:bold>\u2014Cyclosporine pharmacokinetics were determined over the course of 24 hours after oral administration of cyclosporine (5 mg\/kg) alone, cyclosporine with metoclopramide (0.3 to 0.5 mg\/kg), cyclosporine with 2 g of PWG, or cyclosporine combined with both metoclopramide and 2 g of PWG by use of a Latin square crossover study with a 14-day washout period between treatments. Sixty days later, 6 of the 8 dogs were given 10 g of PWG followed by cyclosporine, and pharmacokinetic parameters were compared with those previously obtained after administration of cyclosporine alone.<\/jats:p>\n<jats:p><jats:bold>Results<\/jats:bold>\u2014Although metoclopramide or coadministration of metoclopramide and 2 g of PWG had no effect on the pharmacokinetic parameters of cyclosporine, compared with results for cyclosporine alone, the higher (10-g) dose of PWG resulted in 29% faster mean time to maximal plasma cyclosporine concentration, 54% larger area under the curve, and 38% lower apparent oral clearance.<\/jats:p>\n<jats:p><jats:bold>Conclusions and Clinical Relevance<\/jats:bold>\u2014Adjustment of the cyclosporine dose may not be needed when metoclopramide is coadministered orally to prevent common adverse effects of cyclosporine. Powdered whole grapefruit has the potential to reduce the required orally administered dose of cyclosporine but only when PWG is used in an amount (at least 10 g) that is currently not cost-effective.<\/jats:p>","DOI":"10.2460\/ajvr.72.5.687","type":"journal-article","created":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T07:03:00Z","timestamp":1304233380000},"page":"687-693","source":"Crossref","is-referenced-by-count":17,"title":["Effects of powdered whole grapefruit and metoclopramide on the pharmacokinetics of cyclosporine in dogs"],"prefix":"10.2460","volume":"72","author":[{"given":"Noel E.","family":"Radwanski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Cerundolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances S.","family":"Shofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Court","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"Front Biosci","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2741\/1249","article-title":"Pharmacologic immunosuppression","volume":"9","author":"Barshes","year":"2004"},{"key":"ref2","series-title":"Br J Dermatol","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2133.1997.tb08750.x","article-title":"Long term efficacy and safety of cyclosporine in severe adult atopic dermatitis","volume":"136","author":"Berth-Jones","year":"1997"},{"key":"ref3","series-title":"J Vet Pharmacol Ther","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1365-2885.2004.00587.x","article-title":"Cyclosporine A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs","volume":"27","author":"Steffan","year":"2004"},{"key":"ref4","series-title":"Vet Dermatol","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-3164.2004.00376.x","article-title":"Cyclosporine A: a new drug in the field of canine dermatology","volume":"15","author":"Guagu\u00e9re","year":"2004"},{"key":"ref5","series-title":"Vet Rec","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1136\/vr.152.24.739","article-title":"Review of the pharmacokinetics, interactions and adverse reaction of cyclosporine in people, dogs and cats","volume":"152","author":"Robinson","year":"2003"},{"key":"ref6","series-title":"J Am Hosp Assoc","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5326\/0380205","article-title":"More economical use of cyclosporine through combination drug therapy","volume":"38","author":"Daigle","year":"2002"},{"year":"2003","series-title":"Atopica [package insert]","key":"ref7"},{"key":"ref8","series-title":"Xenobiotica","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/004982599238777","article-title":"Species differences in the hepatic and intestinal metabolism of cyclosporine","volume":"29","author":"Whalen","year":"1999"},{"key":"ref9","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/0140-6736(91)92302-I","article-title":"First-pass metabolism of cyclosporine by the gut","volume":"338","author":"Kolars","year":"1991"},{"key":"ref10","series-title":"J Am Acad Dermatol","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/0190-9622(90)70358-O","article-title":"The role of cytochromes P-450 in cyclosporine metabolism","volume":"23","author":"Watkins","year":"1990"},{"key":"ref11","series-title":"Int J Clin Pharmacol Ther Toxicol","first-page":"555","article-title":"Cyclosporine and ketoconazole drug interaction or therapeutic association?","volume":"30","author":"Albengres","year":"1992"},{"key":"ref12","series-title":"Rev Med Chil","first-page":"1038","article-title":"Cardiac transplantation: economizing cyclosporine A by including ketoconazole in the immunosuppressive schedule [in Spanish]","volume":"19","author":"Becerra","year":"1991"},{"key":"ref13","series-title":"Invest Clin","first-page":"115","article-title":"Usefulness of ketoconazole combined with cyclosporine in renal transplantation","volume":"32","author":"Garcia","year":"1991"},{"key":"ref14","series-title":"Vet Surg","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1532-950X.1998.tb00099.x","article-title":"Effect of ketoconazole on cyclosporine in healthy dogs","volume":"27","author":"Dahlinger","year":"1998"},{"key":"ref15","series-title":"Aust Vet J","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1751-0813.2002.tb10814.x","article-title":"Cyclosporine and ketoconazole interaction for treatment of perianal fistula in the dog","volume":"80","author":"Mouatt","year":"2002"},{"key":"ref16","series-title":"Veterinary drug handbook","first-page":"443","article-title":"Ketoconazole","author":"Plumb","year":"2005"},{"key":"ref17","series-title":"Clin Pharmacol Ther","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0009-9236(95)90032-2","article-title":"Disposition of intravenous and oral cyclosporine after the administration with grapefruit juice","volume":"57","author":"Ducharme","year":"1995"},{"key":"ref18","series-title":"Drug Metab Dispos","first-page":"1228","article-title":"Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP 3A4 concentrations and mechanism-based inactivation by furanocoumarins","volume":"11","author":"Schmiedlin-Ren","year":"1997"},{"key":"ref19","series-title":"J Clin Pharmacol","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/j.1552-4604.1998.tb04393.x","article-title":"Effect of grapefruit juice on the pharmacokinetics of microemulsion cyclosporine and its metabolite in healthy volunteers: does formulation differences matter?","volume":"38","author":"Ku","year":"1998"},{"key":"ref20","series-title":"Clin Pharmacokinet","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2165\/00003088-200038010-00003","article-title":"Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P-450 3A4 inhibition","volume":"38","author":"Dresser","year":"2000"},{"key":"ref21","series-title":"J Rheumatol","first-page":"49","article-title":"Dosing implications of a clinical interaction between grapefruit juice and cyclosporine and metabolite concentrations in patients with autoimmune disease","volume":"24","author":"Ioannides-Demos","year":"1997"},{"key":"ref22","series-title":"Pharmacol Res","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1043-6618(02)00251-7","article-title":"Effects of liquid and freezedried grapefruit juice on the pharmacokinetics of praziquantel and its metabolite 4\u2032-hydroxy praziquantel in beagle dogs","volume":"47","author":"Giorgi","year":"2003"},{"key":"ref23","series-title":"Chem Res Toxicol","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1021\/tx970192k","article-title":"Inactivation of cytochrome P450 3A4 by bergamottin, a compound of grapefruit juice","volume":"11","author":"He","year":"1998"},{"key":"ref24","series-title":"Veterinary drug handbook","first-page":"519","article-title":"Metoclopramide","author":"Plumb","year":"2005"},{"key":"ref25","series-title":"Gut","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/gut.10.12.986","article-title":"Effect of metoclopramide on transport in the small intestine of the dog","volume":"10","author":"Tinker","year":"1969"},{"key":"ref26","series-title":"Transplantation","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00007890-198702000-00009","article-title":"The effect of oral metoclopramide on the absorption of cyclosporine","volume":"43","author":"Wadhwa","year":"1987"},{"key":"ref27","series-title":"Drug Metab Dispos","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1124\/dmd.30.3.336","article-title":"The gastrokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P-450 2D6","volume":"30","author":"Desta","year":"2002"},{"key":"ref28","series-title":"Vet Pharmacol Ther","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2885.2009.01124.x","article-title":"Grapefruit juice, lyophilized grapefruit juice, and powdered whole grapefruit inhibit cytochrome P450-mediated triazolam hydroxylation by Beagle dog liver microsomes","volume":"33","author":"Hanley","year":"2010"},{"key":"ref29","series-title":"Clin Pharmacol Ther","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0009-9236(03)00118-8","article-title":"Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice","volume":"74","author":"Greenblatt","year":"2003"},{"key":"ref30","series-title":"Ther Drug Monit","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/00007691-200608000-00002","article-title":"Sensitive, high throughput HPLC-MS\/MS method with on-line sample clean-up for everolimus measurement","volume":"28","author":"Korecka","year":"2006"},{"key":"ref31","series-title":"Clin Pharmacol Ther","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/clpt.1984.249","article-title":"Effect of metoclopramide on digoxin absorption from tablets and capsules","volume":"36","author":"Johnson","year":"1984"},{"key":"ref32","series-title":"Clin Pharmacokinet","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2165\/00003088-199427060-00004","article-title":"Pharmacokinetic drug interaction with gastromotility modifying agents","volume":"27","author":"Greiff","year":"1994"},{"series-title":"TotalPetSupply. Atopica (cyclosporine modified)","key":"ref33"},{"series-title":"Solution Health Systems","key":"ref34"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/72\/5\/ajvr.72.5.687.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/72\/5\/ajvr.72.5.687.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/72\/5\/ajvr.72.5.687.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:28:07Z","timestamp":1741350487000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/72\/5\/ajvr.72.5.687.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":34,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.72.5.687","relation":{},"ISSN":["0002-9645"],"issn-type":[{"type":"print","value":"0002-9645"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}